Your browser doesn't support javascript.
loading
Low serum lathosterol levels associate with fatal cardiovascular disease and excess all-cause mortality: a prospective cohort study.
Weingärtner, Oliver; Lütjohann, Dieter; Meyer, Sven; Fuhrmann, Arne; Cremers, Bodo; Seiler-Mußler, Sarah; Schött, Hans-F; Kerksiek, Anja; Friedrichs, Silvia; Ulbricht, Ursula; Zawada, Adam; Laufs, Ulrich; Schulze, P Christian; Scheller, Bruno; Fliser, Danilo; Böhm, Michael; Sijbrands, Eric; Heine, Gunnar H.
Afiliación
  • Weingärtner O; Klinik für Innere Medizin I, Universitätsklinikum Jena, Friedrich-Schiller-Universität Jena, Am Klinikum 1, 07747, Jena, Germany. oliver.weingaertner@med.uni-jena.de.
  • Lütjohann D; Abteilung für Kardiologie, Klinikum Oldenburg, European Medical School Oldenburg-Groningen, Oldenburg, Germany. oliver.weingaertner@med.uni-jena.de.
  • Meyer S; Klinik für Innere Medizin I, Universitätsklinikum Jena, Friedrich-Schiller-Universität Jena, Am Klinikum 1, 07747, Jena, Germany.
  • Fuhrmann A; Institut für Klinische Pharmakologie und Klinische Chemie, Universitätsklinikum Bonn, Bonn, Germany.
  • Cremers B; Abteilung für Kardiologie, Klinikum Oldenburg, European Medical School Oldenburg-Groningen, Oldenburg, Germany.
  • Seiler-Mußler S; Institut für Klinische Pharmakologie und Klinische Chemie, Universitätsklinikum Bonn, Bonn, Germany.
  • Schött HF; Klinik für Innere Medizin III, Abteilung für Kardiologie, Angiologie und Internistische Intensivmedizin, Universitätsklinikum des Saarlandes, Homburg, Saar, Germany.
  • Kerksiek A; Klinik für Innere Medizin IV, Abteilung für Nieren-und Hochdruckkrankheiten, Universitätsklinikum des Saarlandes, Homburg, Saar, Germany.
  • Friedrichs S; Institut für Klinische Pharmakologie und Klinische Chemie, Universitätsklinikum Bonn, Bonn, Germany.
  • Ulbricht U; Leibniz-Institut für Analytische Wissenschaften-ISAS-e.V., Dortmund, Germany.
  • Zawada A; Institut für Klinische Pharmakologie und Klinische Chemie, Universitätsklinikum Bonn, Bonn, Germany.
  • Laufs U; Institut für Klinische Pharmakologie und Klinische Chemie, Universitätsklinikum Bonn, Bonn, Germany.
  • Schulze PC; Klinik für Innere Medizin IV, Abteilung für Nieren-und Hochdruckkrankheiten, Universitätsklinikum des Saarlandes, Homburg, Saar, Germany.
  • Scheller B; Klinik für Innere Medizin IV, Abteilung für Nieren-und Hochdruckkrankheiten, Universitätsklinikum des Saarlandes, Homburg, Saar, Germany.
  • Fliser D; Klinik für Innere Medizin III, Abteilung für Kardiologie, Angiologie und Internistische Intensivmedizin, Universitätsklinikum des Saarlandes, Homburg, Saar, Germany.
  • Böhm M; Klinik für Innere Medizin I, Universitätsklinikum Jena, Friedrich-Schiller-Universität Jena, Am Klinikum 1, 07747, Jena, Germany.
  • Sijbrands E; Klinik für Innere Medizin III, Abteilung für Kardiologie, Angiologie und Internistische Intensivmedizin, Universitätsklinikum des Saarlandes, Homburg, Saar, Germany.
  • Heine GH; Klinik für Innere Medizin IV, Abteilung für Nieren-und Hochdruckkrankheiten, Universitätsklinikum des Saarlandes, Homburg, Saar, Germany.
Clin Res Cardiol ; 108(12): 1381-1385, 2019 Dec.
Article en En | MEDLINE | ID: mdl-30949753
ABSTRACT
IMPORTANCE A more precise identification of patients at "high cardiovascular risk" is preeminent in cardiovascular risk stratification.

OBJECTIVE:

To investigate the relationships between markers of cholesterol homeostasis, cardiovascular events and all-cause mortality. DESIGN, SETTING AND

PARTICIPANTS:

We quantified markers of cholesterol homeostasis by gas chromatography-mass spectrometry in 377 subjects with suspected coronary artery disease, who were not on lipid-lowering drugs at baseline. All patients were followed for occurrence of cardiovascular events and mortality over a period of 4.9 +/- 1.7 years. The standardized mortality ratio (SMR) was calculated as the ratio of the observed and the expected deaths based on the death rates of the Regional Databases Germany, and Poisson regression (rate ratio, RR) was used to compare subgroups. The SMR and RR were standardized for sex, age category and calendar period. In addition, Cox regression (Hazard ratio, HR) was used to determine the effect of co-variables on (cardiovascular) mortality within the cohort. MAIN

OUTCOMES:

Cardiovascular events, cardiovascular mortality and all-cause mortality.

RESULTS:

A total of 42 deaths were observed in 1818 person-years corresponding with an SMR of 0.99 (95% CI 0.71-1.33; p = 0.556). A fatal cardiovascular event occurred in 26 patients. Lower levels of lathosterol were associated with increased cardiovascular mortality (HR 1.59; 95% CI 1.16-2.17; p = 0.004) and excess all-cause mortality (HR 1.41; 95% CI 1.09-1.85; p = 0.011). Lower lathosterol tertile compared to the adjacent higher tertile was associated with 1.6 times higher all-cause mortality risk (RR 1.60; 95% CI 1.07-2.40; p for trend = 0.022). This corresponded with a 2.3 times higher mortality risk of a lathosterol-LDL ratio equal to or below the median (RR 2.29; 95% CI 1.19-4.43; p = 0.013). None of the other cholesterol homeostasis markers were associated with cardiovascular and all-cause mortality.

CONCLUSIONS:

In patients not on lipid-lowering agents, low serum lathosterol correlated with increased risk of cardiovascular events and excess all-cause mortality.
Asunto(s)
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Enfermedades Cardiovasculares / Colesterol / Dislipidemias Tipo de estudio: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Clin Res Cardiol Asunto de la revista: CARDIOLOGIA Año: 2019 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Enfermedades Cardiovasculares / Colesterol / Dislipidemias Tipo de estudio: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Clin Res Cardiol Asunto de la revista: CARDIOLOGIA Año: 2019 Tipo del documento: Article